Three people put milk to the test. Low Chromium Increases Risk of Heart Attack
Read More »Health at Every Size: Toward a new Paradigm of Weight and Health
Have you ever heard of HAES (Health At Every Size)? Jon Robison, PhD, MS Executive Co-Director, Michigan Center for Preventive Medicine Department of Kinesiology, Michigan State University has been talking about this concept for years and it might just help your patients to success. To learn more click here.
Read More »Insulin Resistance Raises Risk of Heart Failure
Insulin resistance is an independent risk factor for congestive heart failure, this may, in large part, explain the well-known association between obesity and CHF.
Read More »Statin Does Not Prevent Cardiac Events in Seriously Ill Patients With Type 2 Dia
The investigators speculate that this may be too late in the disease course for therapy to be beneficial.
Read More »Diuretics Best BP Treatment for African-Americans With Metabolic Syndrome
New data fails to support preference for other antihypertensives over diuretics.
Read More »Obesity, Diabetes-Linked Gene Found
French researchers have identified a gene associated with increased risk of obesity and type 2 diabetes in children and adults.
Read More »Changes in Food Subsidies Causes a 38% Fall In Heart Disease
A recent study examined how the policy changes in Poland on diet impacted death rates from heart disease, the world’s number one killer. Aspirin Under-Prescribed to
Read More »ACE Inhibitors and ARBs Have Same Impact on Proteinuria and BP Reduction in Pati
ACE Inhibitors and ARBs Have Same Impact on Proteinuria and BP Reduction in Patients With Diabetic Nephropathy Angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) either alone or in combination appear to have comparable impact in reducing proteinuria and blood pressure in patients with diabetic nephropathy.
Read More »In Type 2, Rosiglitazone Improves Glomerular Filtration, Renal Endothelial Dysfu
In Type 2, Rosiglitazone Improves Glomerular Filtration, Renal Endothelial Dysfunction, and Microalbuminuria in Nephropathy Patients Rosiglitazone ameliorated glomerular hyperfiltration in early type 2 diabetes, improved NO bioavailability, and lessened renal end-organ damage in type 2 diabetes with microalbuminuria.
Read More »Inhaled Insulin Effective Adjunct to Glycemic Control
Use of bolus inhaled insulin along with subcutaneous basal insulin seems comparable to that of subcutaneous basal/bolus insulin in maintaining glycemic control in patients with type 1 diabetes and is equally well tolerated.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.